1315 Capital — 2017 Investments
5 investments dated 2017 · listed companies and verified rows first · show all
BiotechMalvern, US
Vince Burgass(Director)Kevin Rakin(Director)Ashley Freidman(Director)Francis Conway(Executive Officer)Maarten Persenaire(Executive Officer)Antony Koblish(Executive Officer, Director)
Board seatAdele C. Oliva· per SEC Form D · $7.5M raise · filed Jan 2017
HealthtechCarlsbad, US
Stephen Loomis(Executive Officer)M Bolyard(Director)Brian Dovey(Director)Josh Baltzell(Director)Mary Fisher(Executive Officer, Director)Daniell Turner III(Director)
Board seatAdele C. Oliva· per SEC Form D
Onkos Surgical develops orthopaedic implants and an FDA-granted antibacterial coating technology intended to protect implants from bacteria at the time of surgery.
HealthtechMedical DevicesParsippany, US
Board seatAdele C. Oliva· per SEC Form D
HealthtechNewport News, US
William R. Easby-Smith(Director)Gordon Berkstresser(Director)Allan R. Staley(Executive Officer, Director)T. Kerry McCarter(Executive Officer, Director)Guy G. Levy(Executive Officer, Director)David Kaufman(Director)
Board seatMichael Koby· per SEC Form D · $28.3M raise · filed Nov 2017
BiotechRaleigh, US
Margaret Henry(Executive Officer)Cynthia Eckert(Executive Officer, Director)Adele Oliva(Director)Eric Atkins(Executive Officer)Cynthia Whitehead(Executive Officer, Director)
BoardSandra McGlothlin(Director)
Board seatAdele C. Oliva· per SEC Form D · $6.6M raise · filed Jan 2018
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.